Biofourmis Stock

biofourmis.comHealthcare / Digital HealthFounded: 2018

Biofourmis is a health analytics platform designed to analyze physiology data from clinical-grade wearables. The company's platform uses artificial intelligence to integrate and analyze continuous physiology data from clinical-grade wearables to detect personalized patterns and predict clinical exacerbation in advance of a critical event, enabling medical professionals to intervene days before a critical event and providing better outcomes for patients. Biofourmis utilizes machine learning, integrated biometric data and FDA-cleared analytics to streamline patient care.

Register To Buy and Sell Shares

For more details on financing and valuation for Biofourmis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Biofourmis’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Biofourmis.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Kuldeep Singh Rajput
Founder & Chief Executive Officer
Mark Niu
Co-founder & Chief Privacy Officer
Maulik Majmudar, MD
Co-founder & Chief Medical Officer
Milan Shah
Chief Technology Officer
Jaydev Thakkar
Chief Operating Officer
Sheeza Khawar Hussain
Chief Commercial Officer
Matt Borowiecki
Chief Financial Officer
Kirsten Carlson
Chief Marketing Officer

Biofourmis’ stock FAQs


Can you buy Biofourmis’ stock?

Biofourmis is not publicly traded on NYSE or NASDAQ in the U.S. To buy Biofourmis’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Biofourmis’ stock?

Yes, you can sell stock of a private company like Biofourmis. Forge can help you sell your Biofourmis stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Biofourmis’ stock price?

Biofourmis is a privately held company and therefore does not have a public stock price. However, you may access Biofourmis’ private market stock price with Forge Data.

What is Biofourmis’ stock ticker symbol?

Biofourmis does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Biofourmis CEO steps down one month after layoffs

The article discusses the recent decision by Alphabet Inc. to spin off its self-driving car unit, Waymo, into a separate entity. The move aims to increase transparency and accountability, and may potentially attract external investment. Waymo's development progress and future strategy are also highlighted.

Chutes & Ladders‚Amazon One Medical, Biofourmis among high-profile CEO departures

The CEOs of Amazon One Medical and Biofourmis have announced their departures. COO Trent Green will succeed Amir Dan Rubin at One Medical, following Amazon's acquisition of the primary care provider for $3.9 billion in 2022. Meanwhile, Biofourmis is searching for a new CEO after founder Kuldeep Singh Rajput stepped down. The company also added Ben Wanamaker, former VP of enterprise strategy at Humana, to its board of directors.
Updated on: Jul 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.